Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: A morphometric analysis

Nephrology Dialysis Transplantation

Volumn 13, Issue 6, 1998, Pages 1406-1411

  Potier, Mylène ^a,c   Wolf, Armin ^b   Cambar, Jean ^a  

^a UFR Sciences Pharmaceutiques   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Contraction analysis; Cultured mesangial cells; Cyclosporins; Isolated glomeruli; Rat

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN A [8 DEXTRO O (2 HYDROXYETHYL)SERINE]; CYCLOSPORIN DERIVATIVE; CYCLOSPORIN G; UNCLASSIFIED DRUG; OXECLOSPORIN;

ANIMAL CELL; ARTICLE; GLOMERULUS; IMAGE ANALYSIS; KIDNEY CELL CULTURE; MESANGIUM CELL; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL COUNT; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; INCUBATION TIME; MALE; SMOOTH MUSCLE CONTRACTION; SURFACE PROPERTY; TISSUE REACTION;

EID: 0031801466     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.6.1406     Document Type: Article

References (21)

1. Borel JF, Baumann G, Chapman I et al. In vivo pharmacological effects of cyclosporin and some analogues. Adv Pharmacol 1996; 35: 115-246
2. Bennett WM. The nephrotoxicity of immunosuppressive drugs. Clin Nephrol 1995; 43: S3-S7
3. Goldberg HJ, Wong PY, Cole EH, Levy GA, Skorecki KL. Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signalling in mesangial cells. Transplantation 1989; 47: 731-733
4. Burdman EA, Andoh TF, Rosen S et al. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporine G versus cyclosporine A. Kidney Int 1994; 45: 684-691
5. Henry ML, Tesi RJ, Elkhammas EA, Ferguson RM. A randomized, prospective, double-blinded trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report. Transplantation 1993; 55: 751-752
6. Hiestand PC, Grüber M, Hurtenbach U et al. New cyclosporine derivative SDZ IMM 125: In vitro and in vivo pharmacologic effects and toxicologic evaluation. Transplant Proc 1993; 25: 1691-692
7. Whiting PH. Acute and chronic nephrotoxicity associated with immunosuppressive drugs. Curr Opin Nephrol Hypertens 1994; 3: 174-181
8. Barros EJG, Boim MA, Ajzen H, Ramos OL, Schor N. Glomerular hemodynamics and hormonal participation on cyclosporin nephrotoxicity. Kidney Int 1987; 32: 19-25
9. Potier M, L'Azou B, Cambar J. Isolated glomeruli and cultured rat mesangial cells as in vitro models to study immunosuppressive agents. Cell Biol Toxicol 1996; 12: 263-270
10. Ardaillou R, Sraer J, Chansel D, Ardaillou N, Sraer JD. The effect of angiotensin II on isolated glomeruli and cultured mesangial cells. Kidney Int 1987; 31: S74-S80
11. Rodriguez-Puyol D, Lamas S, Olivera A et al. Actions of cyclosporin on cultured rat mesangial cells. Kidney Int 1989; 35: 632-637
12. Mene P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989; 69: 1347-1412
13. Martin-Dupont P, Cambar J. Etude qualitative et quantitative des techniques de tamisage en vue de l'isolement de populations glomérulaires homogènes. Néphrologie 1981; 2: 142-145
14. Foidart JB, Dechenne CA, Mahieu P. Tissue culture of normal rat glomeruli. Invest. Cell Pathol 1979; 2: 15-26
15. Wolf A, Clemann N, Friehauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporin A mediated impairment of renal functions. Transplant Proc 1994; 16: 2902-2907
16. Kreisberg JI, Jeffrey I, Venkatachalam M, Troyer D. Contractile properties of cultured glomerular mesangial cells. Am J Physiol 1985; 249: 457-463
17. Borenfreund E, Puerner JA. Toxicity assessed in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-124
18. Loveland BE, Johns TG, Mackay IR, Vaillant F, Wang ZX, Hertzog PJ. Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem Int 1992; 27: 501-510
19. Langman LJ, Yatscoff RW. The effect of cyclosporine G (OG37-325., cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell lines. Transplant Proc 1994; 26: 3002-3005
20. Muhl H, Kunz D, Rob P, Pfeilschifter J. Cyclosporin derivatives inhibit interleukin 1 beta induction of nitric oxyde synthase in renal mesangial cells. Ear J Pharmacol 1993; 249: 95-100
21. Humbert H, Guest G, Soid MB et al. Steady-state pharmacokinetics of cyclosporine in renal transplant patients: does an influence of age or body weight exist? Transplant Proc 1994; 26: 2791-2797